Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly

Research output: Contribution to journalArticleResearchpeer-review

64 Citations (Scopus)
Original languageEnglish
Pages (from-to)897 - 903
Number of pages7
JournalDrugs & Aging
Volume20
Issue number12
Publication statusPublished - 2003

Cite this